Trials / Completed
CompletedNCT01230008
Radiotherapy in Primary Mediastinal Lymphoma
Adjuvant Radiotherapy in Primary Mediastinal Lymphoma in Patients That Received R-CHOP
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 198 (actual)
- Sponsor
- Instituto Mexicano del Seguro Social · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The use of Rituximab has been proposed to be useful and avoid the use of radiotherapy in diffuse large B-cell lymphoma with bulky disease.We assess efficacy of adjuvant radiotherapy in patients treated with R-CHOP
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | no drugs | Adjuvant radiotherapy 3.5 G will be administered or not (control group) in patients with mediastinal lymphoma,treated with R-CHOP |
Timeline
- Start date
- 2002-06-01
- Primary completion
- 2007-06-01
- Completion
- 2009-12-01
- First posted
- 2010-10-28
- Last updated
- 2010-10-28
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01230008. Inclusion in this directory is not an endorsement.